Introduction
GLP-1 weight-loss injections are one of the most effective medical treatments for people who struggle to lose weight through lifestyle changes alone. These medications, including Mounjaro and Wegovy, help regulate appetite, stabilise blood sugar and support steady long-term weight reduction when used alongside healthy diet and exercise.Many of the benefits of these treatments have been demonstrated in large clinical studies [1][2].
This guide explains how GLP-1 weight-loss treatments work, who they are suitable for, expected results, possible side effects and how to use them safely.
What Are GLP-1 Weight-Loss Medications?
GLP-1 medications belong to a group of treatments known as GLP-1 receptor agonists, which copy the action of a natural hormone that helps control appetite, digestion and blood sugar levels [5].
GLP-1 treatments were originally created for type 2 diabetes and were later found to have significant weight-loss benefits in people without diabetes as well [4].
Examples of GLP-1 weight-loss injections include:
- Mounjaro (tirzepatide). This works on GLP-1 and GIP receptors.
- Wegovy (semaglutide). A weekly GLP-1 injection for weight loss.
- Ozempic (semaglutide). Licensed for diabetes but sometimes used off-label for weight management.
How GLP-1 Weight-Loss Injections Work
GLP-1 medications support weight loss in several clinically proven ways.
1. Reduced appetite
They slow the rate the stomach empties, which helps you feel fuller for longer and reduces snacking [5].
2. Fewer cravings
These medicines act on areas of the brain that regulate hunger and reward, which can reduce cravings and help control portion sizes [6].
3. Better blood sugar control
GLP-1 treatments stabilise blood sugar levels, helping prevent energy dips and reducing cravings for high-sugar foods [4].
4. Balanced hormonal response
They support a healthier insulin response, which can be helpful for people with insulin resistance [4].
5. Steady and sustainable weight loss
Weight typically decreases gradually. Most people notice the biggest changes once they reach a maintenance dose.
Expected Weight-Loss Results
Weight loss varies depending on the medication, the starting dose, adherence and lifestyle changes.
Clinical studies show:
- Wegovy can lead to an average reduction of about 15% of body weight over 68 weeks [1].
- Mounjaro can lead to an average reduction of around 20 to 22.5% at higher doses[2].
These results are higher than those seen with most traditional weight-loss medicines.
Weight tends to reduce slowly and steadily. Most progress happens once the correct maintenance dose has been reached.
Who Is Suitable for GLP-1 Weight-Loss Treatment?
GLP-1 injections may be suitable for people who:
- Have a BMI of 30 or above.
- Have a BMI of 27 or above together with a weight-related condition such as high blood pressure, high cholesterol or pre-diabetes.
- Have struggled to lose weight through lifestyle changes alone.
- Are not pregnant or breastfeeding.
- Are not taking medicines that could interact with GLP-1 treatments.
- Have no medical conditions that make these medicines unsuitable.
These criteria are based on recognised weight management guidance, including NICE recommendations for obesity management [3]
Suitability is carefully checked during the online consultation.
How to Use GLP-1 Weight-Loss Injections
Most GLP-1 injections are taken once a week. Each pen comes with clear instructions for safe and effective use.
Key points to remember:
- Inject into the stomach, thigh or upper arm.
- Rotate injection sites each week.
- Follow the recommended dose increase schedule.
- Do not increase your dose earlier than advised.
- Store the pens correctly. Most are refrigerated before first use.
If you miss a dose, follow the product guidance or contact the pharmacy team for advice.
Dosage and Titration Schedule
GLP-1 treatments start with a low dose so your body can adjust. The dose increases gradually over several weeks.
A typical titration might look like:
- Weeks 1 to 4. Starting dose.
- Weeks 5 to 8. Moderate dose.
- Weeks 9 to 12. Higher dose.
- Maintenance dose. The ongoing weekly dose that suits your response and tolerance.
Exact schedules vary between medications. Each product page will include full details.
Common Weight Loss Injection Side Effects
Most side effects are mild and improve as your body gets used to the medication.
Commonly reported effects include:
- Nausea
- Bloating
- Indigestion
- Diarrhoea or constipation
- Tiredness
- Reduced appetite
- Mild discomfort at the injection site
If side effects persist, dose adjustments or practical steps at home can help. Read our guide to the most common side effects of weight loss medications and how to manage them for further information.
When GLP-1 Weight-Loss Injections Are Not Suitable
These treatments are not suitable for everyone.
They are usually avoided if you have:
- A history of pancreatitis
- Severe digestive conditions
- Certain endocrine disorders
- Pregnancy or breastfeeding
- An allergy to any ingredient in the medication
Your online consultation will check all safety considerations before prescribing.
Start Your GLP-1 Treatment Safely
Complete our quick and secure online consultation. Our pharmacy team will review your answers and advise on the most suitable GLP-1 weight-loss treatment for you.
Browse Weight-Loss Treatments →FAQs
How long do GLP-1 weight-loss injections take to work?
Most people begin to notice a reduction in appetite within the first one to two weeks. Visible weight loss usually becomes noticeable after several weeks, especially once the dose has been increased to a maintenance level.
Do GLP-1 injections work for everyone?
Results vary from person to person and depend on factors such as diet, activity level and how consistently the medication is taken. Many people see steady and sustainable weight loss when treatment is combined with healthy lifestyle changes.
Can I switch from one GLP-1 medication to another?
Switching is possible in some cases, but it depends on your medical history, current treatment and how well you have responded. A pharmacist or prescriber can help decide whether switching is suitable.
Do I need to stay on GLP-1 injections long term?
Some people continue using GLP-1 medicines to support long-term weight management. Others choose to stop once they reach their target. This should always be discussed with a prescriber, as stopping treatment too early may lead to weight regain.
Are GLP-1 injections safe if I have diabetes?
Some GLP-1 medicines are licensed for diabetes and some are licensed for weight loss only. Your consultation will review your medical history and ensure you receive the appropriate product for your needs.
What should I do if I miss a dose?
Most GLP-1 medicines allow a missed dose to be taken within a specific time window. If you miss this window, you may need to skip the injection and return to your normal schedule. Always follow the product instructions or contact the pharmacy team for advice.
What side effects can I expect?
Common side effects include nausea, bloating, indigestion, diarrhoea or constipation, tiredness and reduced appetite. These effects usually improve as your body adjusts. If they persist, dose adjustments or supportive measures may help.
Can I drink alcohol while using GLP-1 injections?
Moderate alcohol consumption is generally safe for many people on GLP-1 treatment, but alcohol can worsen nausea or stomach irritation. People with diabetes or unstable blood sugar should be more cautious.
How do GLP-1 injections help with cravings?
These medications act on areas of the brain that control hunger and reward. This can lead to fewer cravings, reduced snacking and better control over portion sizes.
Are GLP-1 injections suitable for people with stomach conditions?
Some digestive conditions may mean GLP-1 medicines are not suitable. Our pharmacists will check for these conditions during your online consultation and make sure treatment is safe.
References
1. Wegovy (Semaglutide) – Clinical Evidence
• STEP-1 Trial: Once-weekly semaglutide in adults with overweight or obesity – NEJM
• STEP-1 Clinical Trial Registration – ClinicalTrials.gov
• Semaglutide for weight management – PubMed
2. Mounjaro (Tirzepatide) – Clinical Evidence
• SURMOUNT-1 Trial: Tirzepatide for the treatment of obesity (20% weight-loss data) – NEJM
• SURMOUNT-1 Clinical Trial Registration – ClinicalTrials.gov
• Tirzepatide weight-loss outcomes – PubMed
• Tirzepatide dual GLP-1/GIP mechanism – PubMed
3. GLP-1 Receptor Agonist Mechanism
• How GLP-1 medications affect appetite, digestion, and blood sugar – NHS
• Overview of GLP-1 receptor agonists used for weight management – NICE
4. GLP-1 Effects on Blood Sugar & Insulin
• Overview of GLP-1 Agonist Mechanism (Insulin, Glucose & Digestion) – NHS
• Mechanism of Action: GLP-1 and Insulin Production– Diabetes UK
5. NICE Guidance
• NICE CG189 – Obesity: identification, assessment and management – NICE
Medically Reviewed by Our GPhC-Registered Pharmacists
Authored by:
Palvinder DeolSuperintendent Pharmacist
Over 25 years’ clinical experience.
GPhC: 2047066
This article was medically reviewed for accuracy, safety, and alignment with UK clinical standards. Learn about our medical review process →
Content last updated: 24th November 2025 · Next review: December 2025
GPhC Inspection Result
Inspection Outcome: All Standards Met ✅
Our digital-first pharmacy achieved rare “Good Practice” recognition during our GPhC inspection on 19 May 2025 — showcasing our commitment to safe, high-quality and innovative online healthcare.
View full inspection report →GPhC Registration No. 9012585 | Inspected 19 May 2025

